Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1/2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]		 NA phase 1/2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]		 NA phase 2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]		 NA phase 1/2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]		 NA phase 1 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
T-Lymphocyte[MeSHID:D013601]		 NA phase 2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
T-Lymphocyte[MeSHID:D013601]		 NA phase 2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]		 NA phase 2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1/2 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1 unknown
car-t cells targeting cd19 b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
T-Lymphocyte[MeSHID:D013601]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]		 NA phase 1 unknown
click here to return to the previous page